Abstract: The disclosed compositions, systems and methods relate to a dietary supplement for human consumption and comprises 1-methylxanthine and optionally other compounds that modulate the effects of 1-methylxanthine. Uses for the 1-methylxanthine-containing supplements contain improvement of at least one of endurance performance, mood, vigor, lipolysis, energy expenditure, exercise performance, and/or decreased appetite.
Type:
Application
Filed:
August 18, 2025
Publication date:
December 4, 2025
Applicant:
Ingenious ingredients, LP
Inventors:
Martin Purpura, Ralf Jäger, Shawn Wells, Kylin Liao
Abstract: The disclosed compositions, systems and methods relate to a dietary supplement for human consumption and comprises 1-methylxanthine and optionally other compounds that modulate the effects of 1-methylxanthine. Uses for the 1-methylxanthine-containing supplements contain improvement of at least one of endurance performance, mood, vigor, lipolysis, energy expenditure, exercise performance, and/or decreased appetite.
Type:
Grant
Filed:
April 7, 2022
Date of Patent:
August 19, 2025
Assignee:
Ingenious Ingredients, LP
Inventors:
Ralf Jäger, Martin Purpura, Shawn Wells, Kylin Liao
Abstract: The disclosed compositions and methods relate to the increasing muscle mass, preventing muscle atrophy, promoting muscle growth, as well as treatment of various other conditions and diseases. In certain aspects, the disclosed compositions are comprised dileucine and leucine and pharmaceutically acceptable salts thereof. In certain aspects, disclosed compositions are administered to subjects in need thereof to increase muscle mass, prevent muscle atrophy, and/or promote muscle growth.
Type:
Grant
Filed:
April 18, 2019
Date of Patent:
June 8, 2021
Assignee:
Ingenious Ingredients, LP
Inventors:
Martin Purpura, Ralf Jaeger, Shawn Wells, Kylin Lao, Anton Fliri
© 2026 Justia
